Skip to main content
Top
Published in: European Surgery 1/2023

Open Access 09-01-2023 | Antireflux Surgery | Review

Real-world evidence with magnetic sphincter augmentation for gastroesophageal reflux disease: a scoping review

Published in: European Surgery | Issue 1/2023

Login to get access

Summary

Background

The burden of gastroesophageal reflux disease (GERD) is high, with up to 30% of the Western population reporting reflux-related symptoms with or without hiatal hernia. Magnetic sphincter augmentation (MSA) is a standardized laparoscopic procedure for patients who are dissatisfied with medical therapy and for those with early-stage disease who would not usually be considered ideal candidates for fundoplication. The MSA device is manufactured in different sizes and is designed to augment the physiologic barrier to reflux by magnetic force.

Methods

An extensive scoping review was performed to provide a map of current evidence with respect to MSA, to identify gaps in knowledge, and to make recommendations for future research. All the authors contributed to the literature search in PubMed and Web of Science and contributed to summarizing the evidence.

Results

Magnetic sphincter augmentation, especially in combination with crural repair, is effective in reducing GERD symptoms, proton pump inhibitor use, and esophageal acid exposure, and in improving patients’ quality of life. Safety issues such as device erosion or migration have been rare and not associated with mortality. The MSA device can be removed laparoscopically if necessary, thereby preserving the option of fundoplication or other therapies in the future. Contraindication to scanning in high-power Tesla magnetic resonance systems remains a potential limitation of the MSA procedure. High-resolution manometry and functional lumen imaging probes appear to be promising tools to predict procedural outcomes by improving reflux control and reducing the incidence of dysphagia.

Conclusion

A consensus on acquisition and interpretation of high-resolution manometry and impedance planimetry data is needed to gain better understanding of physiology, to improve patient selection, and to pave the way for a personalized surgical approach in antireflux surgery.
Literature
1.
go back to reference Toghanian S, Johnson DA, Stalhammar NO, Zerbib F. Burden of gastro-oesophageal reflux disease in patients with persistent and intense symptoms despite proton-pump inhibitor therapy: a post-hoc analysis of the 2007 national health and wellness survey. Clin Drug Investig. 2011;31:703–15.CrossRef Toghanian S, Johnson DA, Stalhammar NO, Zerbib F. Burden of gastro-oesophageal reflux disease in patients with persistent and intense symptoms despite proton-pump inhibitor therapy: a post-hoc analysis of the 2007 national health and wellness survey. Clin Drug Investig. 2011;31:703–15.CrossRef
2.
go back to reference Kahrilas PJ, Howden CW, Hughes N. Response of regurgitation to proton-pump inhibitor therapy in clinical trials of gastroesophageal reflux disease. Am J Gastroenterol. 2011;106:1419–25.CrossRef Kahrilas PJ, Howden CW, Hughes N. Response of regurgitation to proton-pump inhibitor therapy in clinical trials of gastroesophageal reflux disease. Am J Gastroenterol. 2011;106:1419–25.CrossRef
3.
go back to reference Lord R, DeMeester S, Peters J, et al. Hiatal hernia, lower esophageal sphincter incompetence, and effectiveness of Nissen fundoplication in the spectrum of gastroesophageal reflux disease. J Gastrointest Surg. 2009;13:602–10.CrossRef Lord R, DeMeester S, Peters J, et al. Hiatal hernia, lower esophageal sphincter incompetence, and effectiveness of Nissen fundoplication in the spectrum of gastroesophageal reflux disease. J Gastrointest Surg. 2009;13:602–10.CrossRef
4.
go back to reference Malfertheiner P, Nocon M, Vieth M, et al. Evolution of gastro-oesophageal reflux disease over 5 years under routine medical care—the ProGERD study. Aliment Pharmacol Ther. 2012;35:154–64.CrossRef Malfertheiner P, Nocon M, Vieth M, et al. Evolution of gastro-oesophageal reflux disease over 5 years under routine medical care—the ProGERD study. Aliment Pharmacol Ther. 2012;35:154–64.CrossRef
5.
go back to reference Heidelbaugh JJ, Kim AH, Chang R, et al. Overutilization of proton-pump inhibitors: what the clinician needs to know. Therap Adv Gastroenterol. 2012;5(4):219–32.CrossRef Heidelbaugh JJ, Kim AH, Chang R, et al. Overutilization of proton-pump inhibitors: what the clinician needs to know. Therap Adv Gastroenterol. 2012;5(4):219–32.CrossRef
6.
go back to reference McColl K, Gillen D. Evidence that proton-pump inhibitor therapy induces the symptoms it is used to treat. Gastroenterology. 2009;137:20–2.CrossRef McColl K, Gillen D. Evidence that proton-pump inhibitor therapy induces the symptoms it is used to treat. Gastroenterology. 2009;137:20–2.CrossRef
7.
go back to reference Poulsen AH, Christensen S, McLaughlin JK, et al. Proton pump inhibitors and risk of gastric cancer: a population-based cohort study. Br J Cancer. 2009;100:1503–7.CrossRef Poulsen AH, Christensen S, McLaughlin JK, et al. Proton pump inhibitors and risk of gastric cancer: a population-based cohort study. Br J Cancer. 2009;100:1503–7.CrossRef
8.
go back to reference Stefanidis D, Hope WW, Kohn GP, et al. Guidelines for surgical treatment of gastroesophageal reflux disease. Surg Endosc. 2010;24:2647–69.CrossRef Stefanidis D, Hope WW, Kohn GP, et al. Guidelines for surgical treatment of gastroesophageal reflux disease. Surg Endosc. 2010;24:2647–69.CrossRef
9.
go back to reference Kohn GP, Price RR, DeMeester SR, et al. Guidelines for the management of hiatal hernia. Surg Endosc. 2013;27:4409–28.CrossRef Kohn GP, Price RR, DeMeester SR, et al. Guidelines for the management of hiatal hernia. Surg Endosc. 2013;27:4409–28.CrossRef
10.
go back to reference Fuchs KH, Babic B, Breithaupt W, et al. EAES recommendations for the management of gastroesophageal reflux disease. Surg Endosc. 2014;28:1753–73.CrossRef Fuchs KH, Babic B, Breithaupt W, et al. EAES recommendations for the management of gastroesophageal reflux disease. Surg Endosc. 2014;28:1753–73.CrossRef
11.
go back to reference Galmiche JP, Hatlebakk J, Attwood S, et al. Laparoscopic antireflux surgery vs esomeprazole treatment for chronic GERD: the LOTUS randomized clinical trial. JAMA. 2011;305(19):1969–77.CrossRef Galmiche JP, Hatlebakk J, Attwood S, et al. Laparoscopic antireflux surgery vs esomeprazole treatment for chronic GERD: the LOTUS randomized clinical trial. JAMA. 2011;305(19):1969–77.CrossRef
12.
go back to reference Broeders JA, Mauritz FA, Ahmed Ali U, et al. Systematic review and meta-analysis of laparoscopic Nissen (posterior total) versus Toupet (posterior partial) fundoplication for gastro-oesophageal reflux disease. Br J Surg. 2010;97:1318–30.CrossRef Broeders JA, Mauritz FA, Ahmed Ali U, et al. Systematic review and meta-analysis of laparoscopic Nissen (posterior total) versus Toupet (posterior partial) fundoplication for gastro-oesophageal reflux disease. Br J Surg. 2010;97:1318–30.CrossRef
13.
go back to reference Analatos A, Hakanson BS, Ansorge C, et al. Clinical outcomes of a laparoscopic total vs a 270° posterior partial fundoplication in chronic gastroesophageal reflux disease: a randomized clinical trial. JAMA Surg. 2022;157:473–80.CrossRef Analatos A, Hakanson BS, Ansorge C, et al. Clinical outcomes of a laparoscopic total vs a 270° posterior partial fundoplication in chronic gastroesophageal reflux disease: a randomized clinical trial. JAMA Surg. 2022;157:473–80.CrossRef
14.
go back to reference Markar S, Andreou A, Bonavina L, et al. UEG and EAES rapid guideline: update systematic review, network meta-analysis, CINeMA and GRADE assessment, and evidence-informed European recommendations on surgical management of GERD. United European Gastroenterol J. 2022;10(9):983–98. https://doi.org/10.1002/ueg2.12318.CrossRef Markar S, Andreou A, Bonavina L, et al. UEG and EAES rapid guideline: update systematic review, network meta-analysis, CINeMA and GRADE assessment, and evidence-informed European recommendations on surgical management of GERD. United European Gastroenterol J. 2022;10(9):983–98. https://​doi.​org/​10.​1002/​ueg2.​12318.CrossRef
15.
go back to reference Niebisch S, Fleming FJ, Galey KM, et al. Perioperative risk of laparoscopic fundoplication: safer than previously reported. J Am Coll Surg. 2012;215:61–9.CrossRef Niebisch S, Fleming FJ, Galey KM, et al. Perioperative risk of laparoscopic fundoplication: safer than previously reported. J Am Coll Surg. 2012;215:61–9.CrossRef
16.
go back to reference Richter JE, Dempsey DT. Laparoscopic antireflux surgery: key to success in the community setting. Am J Gastroenterol. 2008;103:289–91.CrossRef Richter JE, Dempsey DT. Laparoscopic antireflux surgery: key to success in the community setting. Am J Gastroenterol. 2008;103:289–91.CrossRef
17.
go back to reference Khajanchee YS, O’Rourke R, Cassera MA, et al. Laparoscopic reintervention for failed antireflux surgery: subjective and objective outcomes in 176 consecutive patients. Arch Surg. 2007;142:785–91.CrossRef Khajanchee YS, O’Rourke R, Cassera MA, et al. Laparoscopic reintervention for failed antireflux surgery: subjective and objective outcomes in 176 consecutive patients. Arch Surg. 2007;142:785–91.CrossRef
18.
go back to reference Finks JF, Wei Y, Birkmeyer JD. The rise and fall of antireflux surgery in the United States. Surg Endosc. 2006;20:1698–701.CrossRef Finks JF, Wei Y, Birkmeyer JD. The rise and fall of antireflux surgery in the United States. Surg Endosc. 2006;20:1698–701.CrossRef
19.
go back to reference Colavita PD, Belyansky I, Walters AL, et al. Nationwide inpatient sample: have antireflux procedures undergone regionalization? J Gastrointest Surg. 2013;17:6–13.CrossRef Colavita PD, Belyansky I, Walters AL, et al. Nationwide inpatient sample: have antireflux procedures undergone regionalization? J Gastrointest Surg. 2013;17:6–13.CrossRef
20.
go back to reference Khan F, Maradey-Romero C, Ganocy S, Frazier R, Fass R. Utilisation of surgical fundoplication for patients with gastro-oesophageal reflux disease in the USA has declined rapidly between 2009 and 2013. Aliment Pharmacol Ther. 2016;43:1124–31.CrossRef Khan F, Maradey-Romero C, Ganocy S, Frazier R, Fass R. Utilisation of surgical fundoplication for patients with gastro-oesophageal reflux disease in the USA has declined rapidly between 2009 and 2013. Aliment Pharmacol Ther. 2016;43:1124–31.CrossRef
22.
go back to reference Labenz J, Chandrasoma PJ, Knapp LJ, DeMeester TR. Proposed approach to the challenging management of progressive gastroesophageal reflux disease. World J Gastrointest Endosc. 2018;10:175–83.CrossRef Labenz J, Chandrasoma PJ, Knapp LJ, DeMeester TR. Proposed approach to the challenging management of progressive gastroesophageal reflux disease. World J Gastrointest Endosc. 2018;10:175–83.CrossRef
23.
go back to reference Pinto D, Plieschnegger W, Schneider NI, et al. Carditis: a relevant marker of gastroesophageal reflux disease. Data from a prospective central European multicenter study on histological and endoscopic diagnosis of esophagitis (histoGERD trial). Dis Esophagus. 2019; https://doi.org/10.1093/dote/doy073.CrossRef Pinto D, Plieschnegger W, Schneider NI, et al. Carditis: a relevant marker of gastroesophageal reflux disease. Data from a prospective central European multicenter study on histological and endoscopic diagnosis of esophagitis (histoGERD trial). Dis Esophagus. 2019; https://​doi.​org/​10.​1093/​dote/​doy073.CrossRef
25.
go back to reference Bonavina L, Saino G, Bona D, et al. Magnetic augmentation of the lower esophageal sphincter: results of a feasibility clinical trial. J Gastrointest Surg. 2008;12:2133–40.CrossRef Bonavina L, Saino G, Bona D, et al. Magnetic augmentation of the lower esophageal sphincter: results of a feasibility clinical trial. J Gastrointest Surg. 2008;12:2133–40.CrossRef
26.
go back to reference DeMeester TR, Ireland AP. Gastric pathology as an initiator and potentiator of gastroesophageal reflux disease. Dis Esophagus. 1997;10:1–8.CrossRef DeMeester TR, Ireland AP. Gastric pathology as an initiator and potentiator of gastroesophageal reflux disease. Dis Esophagus. 1997;10:1–8.CrossRef
28.
go back to reference Siboni S, Bonavina L, Rogers BD, et al. Effect of increased intra-abdominal pressure on the esophagogastric junction: a systematic review. J Clin Gastroenterol. 2022;56:821–30.CrossRef Siboni S, Bonavina L, Rogers BD, et al. Effect of increased intra-abdominal pressure on the esophagogastric junction: a systematic review. J Clin Gastroenterol. 2022;56:821–30.CrossRef
29.
go back to reference Ganz R, Gostout C, Grudem J, et al. Use of a magnetic sphincter for the treatment of GERD: a feasibility study. Gastrointest Endosc. 2008;67:287–94.CrossRef Ganz R, Gostout C, Grudem J, et al. Use of a magnetic sphincter for the treatment of GERD: a feasibility study. Gastrointest Endosc. 2008;67:287–94.CrossRef
30.
go back to reference Buckley FP, Havemann B, Chawla A. Magnetic sphincter augmentation: optimal patient selection and referral care pathways. World J Gastrointest Endosc. 2019;11(8):472–6.CrossRef Buckley FP, Havemann B, Chawla A. Magnetic sphincter augmentation: optimal patient selection and referral care pathways. World J Gastrointest Endosc. 2019;11(8):472–6.CrossRef
31.
32.
go back to reference Ayazi S, Zheng P, Zaidi AH, et al. Magnetic sphincter augmentation and postoperative dysphagia: characterization, clinical risk factors, and management. J Gastrointest Surg. 2020;24:39–49.CrossRef Ayazi S, Zheng P, Zaidi AH, et al. Magnetic sphincter augmentation and postoperative dysphagia: characterization, clinical risk factors, and management. J Gastrointest Surg. 2020;24:39–49.CrossRef
34.
go back to reference Leeds SG, Ebrahim A, Potter EM, et al. The role of preoperative workup in predicting dysphagia, dilation, or explantation after magnetic sphincter augmentation. Surg Endosc. 2020;43:3663–8.CrossRef Leeds SG, Ebrahim A, Potter EM, et al. The role of preoperative workup in predicting dysphagia, dilation, or explantation after magnetic sphincter augmentation. Surg Endosc. 2020;43:3663–8.CrossRef
35.
go back to reference Fletcher R, Dunst C, Abdelmoaty WF, et al. Safety and efficacy of magnetic sphincter augmentation dilation. Surg Endosc. 2021;35(7):3861–4.CrossRef Fletcher R, Dunst C, Abdelmoaty WF, et al. Safety and efficacy of magnetic sphincter augmentation dilation. Surg Endosc. 2021;35(7):3861–4.CrossRef
36.
go back to reference Bonavina L, DeMeester TR, Fockens P, et al. Laparoscopic sphincter augmentation device eliminates reflux symptoms and normalizes esophageal acid exposure. Ann Surg. 2010;252:857–62.CrossRef Bonavina L, DeMeester TR, Fockens P, et al. Laparoscopic sphincter augmentation device eliminates reflux symptoms and normalizes esophageal acid exposure. Ann Surg. 2010;252:857–62.CrossRef
37.
go back to reference Lipham JC, DeMeester TR, Ganz RA, et al. The Linx reflux management system: confirmed safety and efficacy now at 4 years. Surg Endosc. 2012;26:2944–9.CrossRef Lipham JC, DeMeester TR, Ganz RA, et al. The Linx reflux management system: confirmed safety and efficacy now at 4 years. Surg Endosc. 2012;26:2944–9.CrossRef
38.
go back to reference Saino G, Bonavina L, Lipham J, Dunn D, Ganz RA. Magnetic sphincter augmentation for gastroesophageal reflux at 5 years: final results of a pilot study show long-term acid reduction and symptom improvement. J Laparoendosc Adv Surg Tech A. 2015;25:787–92.CrossRef Saino G, Bonavina L, Lipham J, Dunn D, Ganz RA. Magnetic sphincter augmentation for gastroesophageal reflux at 5 years: final results of a pilot study show long-term acid reduction and symptom improvement. J Laparoendosc Adv Surg Tech A. 2015;25:787–92.CrossRef
39.
go back to reference Ganz RA, Peters JH, Horgan S, et al. Esophageal sphincter device for gastroesophageal reflux disease. N Engl J Med. 2013;368:719–27.CrossRef Ganz RA, Peters JH, Horgan S, et al. Esophageal sphincter device for gastroesophageal reflux disease. N Engl J Med. 2013;368:719–27.CrossRef
40.
go back to reference Bonavina L, Saino G, Bona D, et al. One hundred consecutive patients treated with magnetic sphincter augmentation for gastroesophageal reflux disease: 6 years of clinical experience from a single center. J Am Coll Surg. 2013;217:577–85.CrossRef Bonavina L, Saino G, Bona D, et al. One hundred consecutive patients treated with magnetic sphincter augmentation for gastroesophageal reflux disease: 6 years of clinical experience from a single center. J Am Coll Surg. 2013;217:577–85.CrossRef
41.
go back to reference Smith CD, Devault KR, Buchanan M. Introduction of mechanical sphincter augmentation for gastroesophageal reflux disease into practice: early clinical outcomes and keys to successful adoption. J Am Coll Surg. 2014;218:776–81.CrossRef Smith CD, Devault KR, Buchanan M. Introduction of mechanical sphincter augmentation for gastroesophageal reflux disease into practice: early clinical outcomes and keys to successful adoption. J Am Coll Surg. 2014;218:776–81.CrossRef
42.
go back to reference Sheu EG, Nau P, Nath B, Kuo B, Rattner DW. A comparative trial of laparoscopic magnetic sphincter augmentation and Nissen fundoplication. Surg Endosc. 2015;29:505–9.CrossRef Sheu EG, Nau P, Nath B, Kuo B, Rattner DW. A comparative trial of laparoscopic magnetic sphincter augmentation and Nissen fundoplication. Surg Endosc. 2015;29:505–9.CrossRef
43.
go back to reference Czosnyka NM, Buckley FP, Doggett SL, et al. Outcomes of magnetic sphincter augmentation. A community hospital perspective. Am J Surg. 2017;213:1019–23.CrossRef Czosnyka NM, Buckley FP, Doggett SL, et al. Outcomes of magnetic sphincter augmentation. A community hospital perspective. Am J Surg. 2017;213:1019–23.CrossRef
44.
go back to reference Prakash D, Campbell B, Wajed S. Introduction into the NHS of magnetic sphincter augmentation: an innovative surgical therapy for reflux. Results and challenges. Ann R Coll Surg Engl. 2018;100:251–6.CrossRef Prakash D, Campbell B, Wajed S. Introduction into the NHS of magnetic sphincter augmentation: an innovative surgical therapy for reflux. Results and challenges. Ann R Coll Surg Engl. 2018;100:251–6.CrossRef
45.
go back to reference Schwameis K, Nikolic M, Morales Castellano DG, et al. Results of magnetic sphincter augmentation for gastroesophageal reflux disease. World J Surg. 2018;42(10):3263–9.CrossRef Schwameis K, Nikolic M, Morales Castellano DG, et al. Results of magnetic sphincter augmentation for gastroesophageal reflux disease. World J Surg. 2018;42(10):3263–9.CrossRef
46.
go back to reference Antiporda M, Jackson C, Smith CD, Bowers SP. Short-term outcomes predict long-term satisfaction in patients undergoing laparoscopic magnetic sphincter augmentation. J Laparoendosc Adv Surg Tech A. 2019;29(2):198–202.CrossRef Antiporda M, Jackson C, Smith CD, Bowers SP. Short-term outcomes predict long-term satisfaction in patients undergoing laparoscopic magnetic sphincter augmentation. J Laparoendosc Adv Surg Tech A. 2019;29(2):198–202.CrossRef
47.
go back to reference Bell R, Lipham J, Louie BE, et al. Magnetic sphincter augmentation superior to proton pump inhibitors for regurgitation: a 1-year randomized trial. Clin Gastroenterol Hepatol. 2020;18:1736–43.CrossRef Bell R, Lipham J, Louie BE, et al. Magnetic sphincter augmentation superior to proton pump inhibitors for regurgitation: a 1-year randomized trial. Clin Gastroenterol Hepatol. 2020;18:1736–43.CrossRef
48.
go back to reference Warren HF, Brown LM, Milhuro M, et al. Factors influencing the outcome of magnetic sphincter augmentation for chronic GERD. Surg Endosc. 2018;32:405–12.CrossRef Warren HF, Brown LM, Milhuro M, et al. Factors influencing the outcome of magnetic sphincter augmentation for chronic GERD. Surg Endosc. 2018;32:405–12.CrossRef
49.
go back to reference Ward MA, Ebrahim A, Kopita J, et al. Magnetic sphincter augmentation is an effective treatment for atypical symptoms caused by gastroesophageal reflux disease. Surg Endosc. 2020;34:4909–15.CrossRef Ward MA, Ebrahim A, Kopita J, et al. Magnetic sphincter augmentation is an effective treatment for atypical symptoms caused by gastroesophageal reflux disease. Surg Endosc. 2020;34:4909–15.CrossRef
51.
go back to reference Hessler LK, Xu Y, Shada AL, et al. Antireflux surgery leads to durable improvement in laryngopharyngeal reflux symptoms. Surg Endosc. 2022;36(1):778–86.CrossRef Hessler LK, Xu Y, Shada AL, et al. Antireflux surgery leads to durable improvement in laryngopharyngeal reflux symptoms. Surg Endosc. 2022;36(1):778–86.CrossRef
52.
go back to reference Louie BE, Farivar AS, Schultz D, et al. Short-term outcomes using magnetic sphincter augmentation versus Nissen fundoplication for medically resistant gastroesophageal reflux disease. Ann Thorac Surg. 2014;98:498–504.CrossRef Louie BE, Farivar AS, Schultz D, et al. Short-term outcomes using magnetic sphincter augmentation versus Nissen fundoplication for medically resistant gastroesophageal reflux disease. Ann Thorac Surg. 2014;98:498–504.CrossRef
53.
go back to reference Riegler M, Schoppman SF, Bonavina L, et al. Magnetic sphincter augmentation and fundoplication for GERD in clinical practice: one-year results of a multicenter, prospective observational study. Surg Endosc. 2015;29:1123–9.CrossRef Riegler M, Schoppman SF, Bonavina L, et al. Magnetic sphincter augmentation and fundoplication for GERD in clinical practice: one-year results of a multicenter, prospective observational study. Surg Endosc. 2015;29:1123–9.CrossRef
54.
go back to reference Reynolds J, Zehetner J, Wu P, et al. Laparoscopic magnetic sphincter augmentation vs laparoscopic Nissen fundoplication; a matched-pair analysis of 100 patients. Ann Surg. 2015;221:123–8. Reynolds J, Zehetner J, Wu P, et al. Laparoscopic magnetic sphincter augmentation vs laparoscopic Nissen fundoplication; a matched-pair analysis of 100 patients. Ann Surg. 2015;221:123–8.
55.
go back to reference Asti E, Bonitta G, Lovece A, Lazzari V, Bonavina L. Longitudinal comparison of quality of life in patients undergoing laparoscopic Toupet fundoplication versus magnetic sphincter augmentation. Medicine. 2016;95:30.CrossRef Asti E, Bonitta G, Lovece A, Lazzari V, Bonavina L. Longitudinal comparison of quality of life in patients undergoing laparoscopic Toupet fundoplication versus magnetic sphincter augmentation. Medicine. 2016;95:30.CrossRef
56.
go back to reference Warren HF, Reynolds JL, Lipham JC, et al. Multi-institutional outcomes using MSA versus Nissen fundoplication for chronic gastroesophageal reflux disease. Surg Endosc. 2016;30(6):3289–96.CrossRef Warren HF, Reynolds JL, Lipham JC, et al. Multi-institutional outcomes using MSA versus Nissen fundoplication for chronic gastroesophageal reflux disease. Surg Endosc. 2016;30(6):3289–96.CrossRef
57.
go back to reference Bonavina L, Horbach T, Schoppmann SF, DeMarchi J. Three-year clinical experience with magnetic sphincter augmentation and laparoscopic fundoplication. Surg Endosc. 2021;35(7):3449–58.CrossRef Bonavina L, Horbach T, Schoppmann SF, DeMarchi J. Three-year clinical experience with magnetic sphincter augmentation and laparoscopic fundoplication. Surg Endosc. 2021;35(7):3449–58.CrossRef
58.
go back to reference O’Neil S, Jalilvand AD, Colvin JS, Haisley KR, Perry KA. Long-term patient-reported outcomes of laparoscopic magnetic sphincter augmentation vs Nissen fundoplication: a 5-year follow-up study. Surg Endosc. 2022;36:6851–8.CrossRef O’Neil S, Jalilvand AD, Colvin JS, Haisley KR, Perry KA. Long-term patient-reported outcomes of laparoscopic magnetic sphincter augmentation vs Nissen fundoplication: a 5-year follow-up study. Surg Endosc. 2022;36:6851–8.CrossRef
60.
go back to reference Ferrari D, Siboni S, Riva CG, et al. Magnetic sphincter augmentation in severe gastroesophageal reflux disease. Front Med. 2021;8:645592.CrossRef Ferrari D, Siboni S, Riva CG, et al. Magnetic sphincter augmentation in severe gastroesophageal reflux disease. Front Med. 2021;8:645592.CrossRef
61.
go back to reference Schwameis K, Ayazi S, Zheng P, et al. Efficay of magnetic sphincter augmentation across the spectrum of GERD severity. J Am Coll Surg. 2021;232(2):288–97.CrossRef Schwameis K, Ayazi S, Zheng P, et al. Efficay of magnetic sphincter augmentation across the spectrum of GERD severity. J Am Coll Surg. 2021;232(2):288–97.CrossRef
63.
go back to reference Aiolfi A, Asti E, Bernardi D, et al. Early results of magnetic sphincter augmentation versus fundoplication for gastroesophageal reflux disease: systematic review and meta-analysis. Int J Surg. 2018;52:82–8.CrossRef Aiolfi A, Asti E, Bernardi D, et al. Early results of magnetic sphincter augmentation versus fundoplication for gastroesophageal reflux disease: systematic review and meta-analysis. Int J Surg. 2018;52:82–8.CrossRef
64.
65.
go back to reference Rona KA, Reynolds J, Schwameis K, et al. Efficacy of magnetic sphincter augmentation in patients with large hiatal hernias. Surg Endosc. 2017;31(5):2096–102.CrossRef Rona KA, Reynolds J, Schwameis K, et al. Efficacy of magnetic sphincter augmentation in patients with large hiatal hernias. Surg Endosc. 2017;31(5):2096–102.CrossRef
66.
go back to reference Kuckelman JP, Phillips CJ, Hardin MO, et al. Standard vs expanded indications for esophageal magnetic sphincter augmentation for reflux disease. JAMA Surg. 2017;152(9):890–1.CrossRef Kuckelman JP, Phillips CJ, Hardin MO, et al. Standard vs expanded indications for esophageal magnetic sphincter augmentation for reflux disease. JAMA Surg. 2017;152(9):890–1.CrossRef
67.
go back to reference Buckley FP, Bell RCW, Freeman K, et al. Favorable results from a prospective evaluation of 200 patients with large hiatal hernias undergoing LINX magnetic sphincter augmentation. Surg Endosc. 2018;32:1762–8.CrossRef Buckley FP, Bell RCW, Freeman K, et al. Favorable results from a prospective evaluation of 200 patients with large hiatal hernias undergoing LINX magnetic sphincter augmentation. Surg Endosc. 2018;32:1762–8.CrossRef
68.
go back to reference Schwameis K, Nikolic M, Morales Castellano DG, et al. Crural closure improves outcomes of magnetic sphincter augmentation in GERD patients with hiatal hernia. Sci Rep. 2018;8:7319.CrossRef Schwameis K, Nikolic M, Morales Castellano DG, et al. Crural closure improves outcomes of magnetic sphincter augmentation in GERD patients with hiatal hernia. Sci Rep. 2018;8:7319.CrossRef
69.
go back to reference Tatum JM, Alicuben E, Bildzukewicz N, et al. Minimal versus obligatory dissection of the diaphragmatic hiatus during magnetic sphincter augmentation surgery. Surg Endosc. 2019;33:782–8.CrossRef Tatum JM, Alicuben E, Bildzukewicz N, et al. Minimal versus obligatory dissection of the diaphragmatic hiatus during magnetic sphincter augmentation surgery. Surg Endosc. 2019;33:782–8.CrossRef
70.
go back to reference Dunn C, Zhao J, Wang JC, et al. Magnetic sphincter augmentation with hiatal repair: long-term outcomes. Surg Endosc. 2021;35(10):5607–12.CrossRef Dunn C, Zhao J, Wang JC, et al. Magnetic sphincter augmentation with hiatal repair: long-term outcomes. Surg Endosc. 2021;35(10):5607–12.CrossRef
71.
go back to reference Irribarra MM, Blitz S, Wilshire CL, et al. Does treatment of the hiatus influence the outcomes of magnetic sphincter augmentation for chronic GERD? J Gastrointest Surg. 2019;23:1104–12.CrossRef Irribarra MM, Blitz S, Wilshire CL, et al. Does treatment of the hiatus influence the outcomes of magnetic sphincter augmentation for chronic GERD? J Gastrointest Surg. 2019;23:1104–12.CrossRef
72.
go back to reference Alicuben ET, Tatum JM, Bildzukewicz N, et al. Regression of intestinal metaplasia following magnetic sphincter augmentation device placement. Surg Endosc. 2019;33:576–9.CrossRef Alicuben ET, Tatum JM, Bildzukewicz N, et al. Regression of intestinal metaplasia following magnetic sphincter augmentation device placement. Surg Endosc. 2019;33:576–9.CrossRef
73.
go back to reference Dunn CP, Henning JC, Sterris JA, et al. Regression of Barrett’s esophagus after magnetic sphincter augmentation: intermediate-term results. Surg Endosc. 2021;35(10):5804–9.CrossRef Dunn CP, Henning JC, Sterris JA, et al. Regression of Barrett’s esophagus after magnetic sphincter augmentation: intermediate-term results. Surg Endosc. 2021;35(10):5804–9.CrossRef
75.
go back to reference Ferrari D, Asti E, Lazzari V, et al. Six to 12-year outcomes of magnetic sphincter augmentation for gastroesophageal reflux disease. Sci Rep. 2020;10:13753.CrossRef Ferrari D, Asti E, Lazzari V, et al. Six to 12-year outcomes of magnetic sphincter augmentation for gastroesophageal reflux disease. Sci Rep. 2020;10:13753.CrossRef
76.
go back to reference Lipham JC, Taiganides PA, Louie BE, et al. Safety analysis of first 1000 patients treated with magnetic sphincter augmentation for gastroesophageal reflux disease. Dis Esophagus. 2015;28:305–11.CrossRef Lipham JC, Taiganides PA, Louie BE, et al. Safety analysis of first 1000 patients treated with magnetic sphincter augmentation for gastroesophageal reflux disease. Dis Esophagus. 2015;28:305–11.CrossRef
77.
go back to reference Ganz RA, Edmundowicz SA, Taiganides PA, et al. Long-term outcomes of patients receiving a magnetic sphincter augmentation device for gastroesophageal reflux. Clin Gastroenterol Hepatol. 2016;14:671–7.CrossRef Ganz RA, Edmundowicz SA, Taiganides PA, et al. Long-term outcomes of patients receiving a magnetic sphincter augmentation device for gastroesophageal reflux. Clin Gastroenterol Hepatol. 2016;14:671–7.CrossRef
78.
go back to reference Smith CD, Ganz RA, Lipham JC, Bell RC, Rattner DW. Lower esophageal sphincter augmentation for gastroesophageal reflux disease: the safety of a modern implant. J Laparoendosc Adv Surg Tech A. 2017;27:586–91.CrossRef Smith CD, Ganz RA, Lipham JC, Bell RC, Rattner DW. Lower esophageal sphincter augmentation for gastroesophageal reflux disease: the safety of a modern implant. J Laparoendosc Adv Surg Tech A. 2017;27:586–91.CrossRef
79.
go back to reference Bologheanu M, Matic A, Feka J, et al. Severe dysphagia is rare after magnetic sphincter augmentation. World J Surg. 2022;46(9):2243–50.CrossRef Bologheanu M, Matic A, Feka J, et al. Severe dysphagia is rare after magnetic sphincter augmentation. World J Surg. 2022;46(9):2243–50.CrossRef
80.
go back to reference Asti E, Siboni S, Lazzari V, et al. Removal of the magnetic sphincter device. Surgical technique and results of a single-center cohort study. Ann Surg. 2017;265:941–5.CrossRef Asti E, Siboni S, Lazzari V, et al. Removal of the magnetic sphincter device. Surgical technique and results of a single-center cohort study. Ann Surg. 2017;265:941–5.CrossRef
81.
go back to reference Ganz RA. A modern magnetic implant for gastroesophageal reflux disease. Clin Gastroenterol Hepatol. 2017;15:1326–37.CrossRef Ganz RA. A modern magnetic implant for gastroesophageal reflux disease. Clin Gastroenterol Hepatol. 2017;15:1326–37.CrossRef
83.
go back to reference Alicuben ET, Bell RC, Jobe BA, et al. Worldwide experience with erosion of the magnetic sphincter augmentation device. J Gastrointest Surg. 2018;22:1442–7.CrossRef Alicuben ET, Bell RC, Jobe BA, et al. Worldwide experience with erosion of the magnetic sphincter augmentation device. J Gastrointest Surg. 2018;22:1442–7.CrossRef
84.
go back to reference DeMarchi J, Schwiers M, Soberman M, Tokarski A. Evolution of a novel technology for gastroesophageal reflux disease: a safety perspective of magnetic sphincter augmentation. Dis Esophagus. 2021;34:1–7.CrossRef DeMarchi J, Schwiers M, Soberman M, Tokarski A. Evolution of a novel technology for gastroesophageal reflux disease: a safety perspective of magnetic sphincter augmentation. Dis Esophagus. 2021;34:1–7.CrossRef
85.
go back to reference Riva CG, Siboni S, Sozzi M, et al. High-resolution manometry findings after Linx procedure for gastro-esophageal reflux disease. Neurogastroenterol Motil. 2020;32:e13750.CrossRef Riva CG, Siboni S, Sozzi M, et al. High-resolution manometry findings after Linx procedure for gastro-esophageal reflux disease. Neurogastroenterol Motil. 2020;32:e13750.CrossRef
87.
go back to reference Siboni S, Ferrari D, Riva CG, et al. Reference high-resolution manometry values after magnetic sphincter augmentation. Neurogastroenterol Motil. 2021;33:e14139.CrossRef Siboni S, Ferrari D, Riva CG, et al. Reference high-resolution manometry values after magnetic sphincter augmentation. Neurogastroenterol Motil. 2021;33:e14139.CrossRef
88.
go back to reference Ayazi S, Grubic AD, Zheng P, et al. Measurement of outflow resistance imposed by magnetic sphincter augmentation: defining normal values and clinical implications. Surg Endosc. 2021;35:5787–95.CrossRef Ayazi S, Grubic AD, Zheng P, et al. Measurement of outflow resistance imposed by magnetic sphincter augmentation: defining normal values and clinical implications. Surg Endosc. 2021;35:5787–95.CrossRef
89.
go back to reference Dominguez-Profeta R, Cheverie JN, Blitzer RR, et al. More beads, more peristaltic reserve, better outcomes: factors predicting postoperative dysphagia after magnetic sphincter augmentation. Surg Endosc. 2021;35(9):5295–302.CrossRef Dominguez-Profeta R, Cheverie JN, Blitzer RR, et al. More beads, more peristaltic reserve, better outcomes: factors predicting postoperative dysphagia after magnetic sphincter augmentation. Surg Endosc. 2021;35(9):5295–302.CrossRef
91.
go back to reference Ayazi S, Schwameis K, Zheng P, et al. Establishing preoperative risk factors and development of a predictive nomogram for dysphagia after magnetic sphincter augmentation. J Am Coll Surg. 2020;231:e1–e2.CrossRef Ayazi S, Schwameis K, Zheng P, et al. Establishing preoperative risk factors and development of a predictive nomogram for dysphagia after magnetic sphincter augmentation. J Am Coll Surg. 2020;231:e1–e2.CrossRef
92.
go back to reference O’ Dea J. Measurement of esophagogastric junction distensibility may assist in selecting patients for endoluminal gastroesophageal reflux disease surgery. J Neurogastroenterol Motil. 2015;21(3):448.CrossRef O’ Dea J. Measurement of esophagogastric junction distensibility may assist in selecting patients for endoluminal gastroesophageal reflux disease surgery. J Neurogastroenterol Motil. 2015;21(3):448.CrossRef
93.
go back to reference Stefanova DI, Limberg JN, Ullmann TM, et al. Quantifying factors essential to the integrity of the esophagogastric junction during antireflux procedures. Ann Surg. 2020;272:488–94.CrossRef Stefanova DI, Limberg JN, Ullmann TM, et al. Quantifying factors essential to the integrity of the esophagogastric junction during antireflux procedures. Ann Surg. 2020;272:488–94.CrossRef
94.
go back to reference DeHaan RK, Davila D, Frelich MJ, et al. Esophagogastric junction distensibility is greater following Toupet compared to Nissen fundoplication. Surg Endosc. 2017;31:193–8.CrossRef DeHaan RK, Davila D, Frelich MJ, et al. Esophagogastric junction distensibility is greater following Toupet compared to Nissen fundoplication. Surg Endosc. 2017;31:193–8.CrossRef
95.
go back to reference Wu H, Attaar M, Wong HJ, et al. Impedance planimetry (EndoFLIPTM) reveals changes in gastroesophageal junction compliance during fundoplication. Surg Endosc. 2022;36:6801–8.CrossRef Wu H, Attaar M, Wong HJ, et al. Impedance planimetry (EndoFLIPTM) reveals changes in gastroesophageal junction compliance during fundoplication. Surg Endosc. 2022;36:6801–8.CrossRef
96.
go back to reference Su B, Dunst C, Gould J, et al. Experience-based expert consensus on the intra-operative usage of the Endoflip impedance planimetry system. Surg Endosc. 2021;35:2731–42.CrossRef Su B, Dunst C, Gould J, et al. Experience-based expert consensus on the intra-operative usage of the Endoflip impedance planimetry system. Surg Endosc. 2021;35:2731–42.CrossRef
97.
go back to reference Wu H, Attaar M, Wong HJ, et al. Impedance planimetry (EndoFLIPTM) after magnetic sphincter augmentation (LINX®) compared to fundoplication. Surg Endosc. 2022;36:7709–16.CrossRef Wu H, Attaar M, Wong HJ, et al. Impedance planimetry (EndoFLIPTM) after magnetic sphincter augmentation (LINX®) compared to fundoplication. Surg Endosc. 2022;36:7709–16.CrossRef
98.
go back to reference Bredenoord AJ, Rancati F, Lin H, et al. Normative values for esophageal functional lumen imaging probe measurements: a meta-analysis. Neurogastroenterol Motil. 2022;34:e14419.CrossRef Bredenoord AJ, Rancati F, Lin H, et al. Normative values for esophageal functional lumen imaging probe measurements: a meta-analysis. Neurogastroenterol Motil. 2022;34:e14419.CrossRef
99.
go back to reference Su B, Novak S, Callahan ZM, et al. Using impedance planimetry (EndoFLIPTM) in the operating room to assess gastroesophageal junction distensibility and predict patient outcomes following fundoplication. Surg Endosc. 2020;34:1761–8.CrossRef Su B, Novak S, Callahan ZM, et al. Using impedance planimetry (EndoFLIPTM) in the operating room to assess gastroesophageal junction distensibility and predict patient outcomes following fundoplication. Surg Endosc. 2020;34:1761–8.CrossRef
100.
go back to reference Wu H, Attaar M, Wong HJ, et al. Impedance planimetry (EndoFLIP) measurements persist long-term after anti-reflux surgery. Surgery. 2022;171:628–34.CrossRef Wu H, Attaar M, Wong HJ, et al. Impedance planimetry (EndoFLIP) measurements persist long-term after anti-reflux surgery. Surgery. 2022;171:628–34.CrossRef
Metadata
Title
Real-world evidence with magnetic sphincter augmentation for gastroesophageal reflux disease: a scoping review
Publication date
09-01-2023

Other articles of this Issue 1/2023

European Surgery 1/2023 Go to the issue

book review

Book review